Aurinia Pharmaceuticals
AUPH
#4832
Rank
NZ$3.18 B
Marketcap
NZ$24.13
Share price
-0.82%
Change (1 day)
69.98%
Change (1 year)

Market capitalization of Aurinia Pharmaceuticals (AUPH)

Market cap: NZ$3.18 Billion

As of January 2026 Aurinia Pharmaceuticals has a market cap of NZ$3.18 Billion. This makes Aurinia Pharmaceuticals the world's 4832th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Aurinia Pharmaceuticals from 2009 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$3.18 B-14.02%
2025NZ$3.69 B58.38%
2024NZ$2.33 B14.41%
2023NZ$2.04 B111.13%
2022NZ$0.96 B-77.73%
2021NZ$4.34 B79.74%
2020NZ$2.41 B-27.7%
2019NZ$3.34 B284.69%
2018NZ$0.86 B61.22%
2017NZ$0.53 B347.47%
2016NZ$0.12 B1.76%
2015NZ$0.11 B-18.51%
2014NZ$0.14 B161.86%
2013NZ$55.44 M327.72%
2012NZ$12.96 M-50.52%
2011NZ$26.19 M-50.19%
2010NZ$52.58 M84.57%
2009NZ$28.48 M

End of Day market cap according to different sources

On Jan 30th, 2026 the market cap of Aurinia Pharmaceuticals was reported to be:

NZ$3.18 Billion
by Nasdaq info icon info icon
NZ$3.18 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
NZ$130.48 B 4,002.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
NZ$29.81 M-99.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
NZ$29.07 M-99.09%๐Ÿ‡บ๐Ÿ‡ธ USA